Send to

Choose Destination
Pneumologe (Berl). 2020 Mar 23:1-10. doi: 10.1007/s10405-020-00313-w. [Epub ahead of print]

[Treatment of complications and nonpharmacological management of idiopathic pulmonary fibrosis].

[Article in German]

Author information

1Klinik für Innere Medizin - Pneumologie und Infektiologie, Vivantes Kliniken Neukölln und Spandau, Forschungsbereich Pneumologie und Pneumologische Epidemiologie, Universitätsmedizin Greifswald, Greifswald, Deutschland.
2Forschungsinstitut für Pneumologische Rehabilitation, Schön Klinik Berchtesgadener Land, Schönau am Königssee und Zentrum für Prävention und Sportmedizin, Technische Universität München, München, Deutschland.
3Zentrum für interstitielle und seltene Lungenerkrankungen, Klink für Pneumologie, Ruhrlandklinik, Universitätsmedizin Essen, Essen, Deutschland.


Complications of idiopathic pulmonary fibrosis (IPF) are responsible for a relevant proportion of the mortality. Most importantly, acute exacerbation leads to an in-hospital mortality of more than 50% with a mean survival time of only a few months. Therefore, consideration of complications in IPF is of great importance for understanding the disease and treatment planning. Furthermore, the evidence for pneumological rehabilitation in IPF has greatly increased. This resulted in specific recommendations by the American Thoracic Society (ATS) and the European Respiratory Society (ERS) for improvement in physical capacity, quality of life and symptom control.


Complications; Exacerbation; Pulmonary hypertension; Rehabilitation; Training

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center